Attenuation of counterregulatory responses to recurrent hypoglycemia by active thalamic inhibition a mechanism for hypoglycemia-associated autonomic failure

Diabetes

Volumn 57, Issue 2, 2008, Pages 470-475

  Arbelaez, Ana Maria ^a   Powers, William J ^a,b   Videen, Tom O ^a   Price, Joseph L ^a   Cryer, Philip E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WATER O 15; C PEPTIDE; GLUCOSE; INSULIN; OXYGEN;

ADRENERGIC SYSTEM; ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; BRAIN BLOOD FLOW; BRAIN FUNCTION; COMPARATIVE STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; HYPOGLYCEMIA; HYPOGLYCEMIA ASSOCIATED AUTONOMIC FAILURE; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT DISEASE; SYNAPSE; THALAMUS; BLOOD; BRAIN CIRCULATION; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HYPOTHALAMUS; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; REFERENCE VALUE;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; CEREBROVASCULAR CIRCULATION; FEMALE; GLUCOSE; HOMEOSTASIS; HUMANS; HYPOGLYCEMIA; HYPOTHALAMUS; INFUSIONS, INTRAVENOUS; INSULIN; MAGNETIC RESONANCE IMAGING; MALE; OXYGEN RADIOISOTOPES; POSITRON-EMISSION TOMOGRAPHY; RECURRENCE; REFERENCE VALUES;

EID: 40749137051     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-1329     Document Type: Article

References (55)

1. Cryer PE: Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 350:2272-2279, 2004
2. Dagogo-Jack SE, Craft S, Cryer PE: Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. J Clin Invest 91:819-828,1993
3. Segel SA, Paramore DS, Cryer PE: Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 51:724-733, 2002
4. DeRosa MA, Cryer PE: Hypoglycemia and the sympathoadrenal system:neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation. Am, J Physiol Endocrinol Metab 287:E32-E41, 2004
5. Gold AE, MacLeod KM, Frier BM: Frequency of severe hypoglycemia in patients with type 1 diabetes with impaired awareness of hypoglycemia. Diabetes Care 17:697-703, 1994
6. White NH, Skor DA, Cryer PE, Levandoski LA, Bier DM, Santiago JV:Identification of type 1 diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med 308:485-491, 1983
7. Bolli GB, De Feo P, De Cosmo S, Perriello G, Ventura MM, Benedetti MM, Santeusanio F, Gerich JE, Brunetti P: A reliable and reproducible test for adequate glucose counterregulation in type 1 diabetes. Diabetes 33:732-737, 1984
8. Ertl AC, Davis SN: Evidence for a vicious cycle of exercise and hypoglycemia in type 1 diabetes mellitus. Diabete Metab Res Rev 20:124-130, 2004
9. Banarer S, Cryer PE: Sleep-related hypoglycemia-associated autonomic failure in type 1 diabetes: reduced awakening from sleep during hypogly-cemia. Diabetes 52:1195-1203, 2003
10. Segel SA, Fanelli CG, Dence CS, Markham J, Videen TO, Paramore DS, Powers WJ, Cryer PE: Blood-to-brain glucose transport, cerebral glucose metabolism and cerebral blood flow are not increased following hypoglycemia. Diabetes 50:1911-1917, 2001
11. Cryer PE: Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes 54:3592-3601, 2005
12. Cryer PE: Mechanisms of sympathoadrenal failure and hypoglycemia in diabetes. J Clin Invest 116:1470-1473, 2006
13. Raichle ME: Behind the scenes of functional brain imaging: a historical and physiological perspective. Proc Natl Acad Sci U S A 95:765-772, 1998
14. Teves D, Videen TO, Cryer PE, Powers WJ: Activation of human medial prefrontal cortex during autonomic responses to hypoglycemia. Proc Natl Acad Sci U S A 101:6217-6221, 2004
15. Shah SD, Clutter WE, Cryer PE: External and internal standards in the single isotope derivative (radioenzymatic) measurement of plasma norepinephrine and epinephrine. J Lab Clin Med 106:624-629, 1985
16. Kuzuya H, Blix PM, Horwitz DL, Steiner DF, Rubenstein AH: Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 26:22-29, 1977
17. Ensinck J: Immunoassays for glucagon. In Handbook of Experimental Pharmacology. Vol. 66, Lefebrve P, Ed. New York, Springer Verlag, 1983, p.203-221
18. Gingerich RL, Lacy PE, Chance RE, Johnson MG: Regional pancreatic concentration and in vitro secretion of canine pancreatic polypeptide, insulin and glucagon. Diabetes 27:96-101, 1978
19. Farmer RW, Pierce CE: Plasma cortisol determination: radioimmunoassay and competitive protein binding compared. Clin Chem 20:411-414, 1974
20. Schlach D, Parker M: A sensitive double antibody radioimmunoassay for growth hormone in plasma. Nature 703:1141-1142, 1964
21. Hosaka K, Kikuchi T, Mitsuhida N, Kawaguchi A: A new colorimetric method for determination of free fatty acids with acyl-CoA synthase and acyl-CoA oxidase. J Biochem (Tokyo) 89:1799-1803, 1981
22. Lowry O, Passoneau J, Hasselberger F, Schultz D: Effect of ischemia on known substrates and co-factors of the glycolytic pathway of the brain.J Biol Chem 239:18-30, 1964
23. Wienhard K, Dahlbom M, Ericksson L, Michel C, Bruckbauer T, Pietrzyk U, Heiss WD: The ECAT EXACT HR: performance of a new high resolution positron scanner. J Comput Assist Tomogr 18:110-118, 1994
24. Herscovitch P, Markham J, Raichle MR: Brain blood flow measured with intravenous H2(15)O. I. Theory and error analysis. J Nucl Med 24:782-789,1983
25. Raichle ME, Martin WR, Herscovitch P, Mintun MA, Markham J: Brain blood flow measured with intravenous H2(15)O. II. Implementation and validation. Nucl Med 24:790-798, 1983
26. Videen TO, Perlmutter JS, Herscovitch P, Raichle ME: Brain blood volume, flow, and oxygen utilization measured with 15O radiotracers and positron emission tomography: revised metabolic computations. Cereb Blood Flow Metab 7:513-516, 1987
27. Woods RP, Cherry SR, Mazziotta JC: Rapid automated algorithm for aligning and reslicing PET images. J Comput Assist Tomogr 16:620-633,1992
28. Talairach J, Tournoux P: Co-Planar Stereotaxic Atlas of the Human Brain. New York, Thieme, 1988
29. 15O]butanol and positron emission tomography. J Cereb Blood Flow Metab 14:628-638, 1994
30. SPM (by members & collaborators of the Wellcome Department of Imaging Neuroscience): Statistical Parametric Mapping [Web site]. Available from http://www.fil.ion.ucl.ac.uk/spm/. Accessed 24 December 2007
31. Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RSJ:Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 2:189-210, 1995
32. Worsley KJ, Marrett S, Neelin P, Vandal AC, Friston KJ, Evans AC: A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp 4:58-73, 1996
33. Rieck RW, Ansari MS, Whetsell WO Jr, Deutch AY, Kessler RM: Distribution of dopamine D2-like receptors in the human thalamus: autoradio-graphic and PET studies. Neuropsychopharmacology 29:362-372, 2004
34. Powers WJ, Hirsch IB, Cryer P: Effect ofstepped hypoglycemia on regional cerebral blood flow response to physiological brain activation. Am J Physiol 270:H554-H559, 1996
35. Matthew E, Andreason P, Carson RE, Herscovitch P, Pettigrew K, Cohen R, King C, Johanson CE, Paul SM: Reproducibility of resting cerebral blood flow measurements with H2(15)O positron emission tomography in humans. J Cereb Blood Flow Metab 13:748-754, 1993
36. Bartlett EJ, Brodie JD, Wolf AP, Christman DR, Laska E, Meissner M:Reproducibility of cerebral glucose metabolic measurements in resting human subjects. J Cereb Blood Flow Metab 8:502-512, 1988
37. Stapleton JM, Morgan MJ, Liu X, Yung BCK, Phillips RL, Wong DF, Shaya EK, Dannals RF, London ED: Cerebral glucose utilization is reduced in second test session. J Cereb Blood Flow Metab 17:704-712, 1997
38. Mathiesen C, Caesar K, Akgoren N, Lauritzen M: Modification of activity-dependent increases of cerebral blood flow by excitatory synaptic activity and spikes in rat cerebellar cortex. J Physiol 512:555-566, 1998
39. Schwartz WJ, Smith CB, Davidsen L, Savaki H, Sokoloff L, Mata M, Fink DJ, Gainer H: Metabolic mapping of functional activity in the hypothalamo- neurohypophysial system of the rat. Science 205:723-725, 1979
40. Borg WP, During MJ, Sherwin RS, Borg MA, Brines ML, Shulman GI:Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia. J Clin Invest 93:1677-1682, 1994
41. Borg MA, Sherwin RS, Borg WP, Tamborlane WV, Shulman GI: Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. J Clin Invest 99:361-365, 1997
42. Borg WP, Sherwin RS, During MJ, Borg MA, Shulman GI: Local ventrome-dial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes 44:180-184, 1995
43. Borg MA, Borg WP, Tamborlane WV, Brines ML, Shulman GI, Sherwin RS:Chronic hypoglycemia and diabetes impair counterregulation induced by localized 2-deoxy-glucose perfusion of the ventromedial hypothalamus in rats. Diabetes 48:584-587, 1999
44. Bhatnagar S, Huber R, Nowak N, Trotter P: Lesions of the posterior paraventricular thalamus block habituation of hypothalamic-pituitary-adrenal responses to repeated restraint. J Neuroendocrinol 14:403-410,2002
45. Bhatnagar S, Viau V, Chu A, Soriano L, Meijer OC, Dallman MF: A cholecystokinin-mediated pathway to the paraventricular thalamus is recruited in chronically stressed rats and regulates hypothalamic-pituitary-adrenal function. J Neurosci 20:5564-5573, 2000
46. Otake K, Kin K, Nakamura Y: Fos expression in afferents to the rat midline thalamus following immobilization stress. Neurosci Res 43:269-282, 2002
47. Ongur D, Price JL: The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb Cortex 10:206-219, 2000
48. Herman JP, Figueiredo H, Mueller NK, Ulrich-Lai Y, Ostrander MM, Choi DC, Cullinan WE: Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol 24:151-180, 2003
49. Moga MM, Weis RP, Moore RY: Efferent projections of the paraventricular thalamic nucleus in the rat. J Comp Neurol 359:221-238, 1995
50. Spencer SJ, Fox JC, Day TA: Thalamic paraventricular nucleus lesions facilitate central amygdala neuronal responses to acute psychological stress. Brain Res 997:234-237, 2004
51. Huang H, Ghosh P, van den Pol AN: Prefrontal cortex-projecting glutama-tergic thalamic paraventricular nucleus-excited by hypocretin: a feedforward circuit that may enhance cognitive arousal. J Neurophysiol 95:1656 1668, 2006
52. Rempel-Clower NL, Barbas H: Topographic organization of connections between the hypothalamus and the prefrontal cortex in the rhesus monkey. J Comp Neurol 398:393-419, 1998
53. Figueiredo HF, Bruestle A, Bodie B, Dolgas CM, Herman JP: The medial prefrontal cortex differentially regulates stress-induced c-fos expression in the forebrain depending on type of stressor. Eur J Neurosci 18:2357-2364,2003
54. 18F-fluorodeoxyglucose uptake at hypoglycemia in type 1 diabetic men associated with hypoglycemia unawareness and counter-regulatory failure. Diabetes 50:2329-2366, 2001
55. Perlmutter JS, Mink JW: Deep brain stimulation. Annu Rev Neurosci 29:229-257, 2006